ナノマテリアルの有害性評価 : 毒性評価(誌上シンポジウム)  [in Japanese] Hazard Identification of Nanomaterials(Symposium Review)  [in Japanese]

    • 津田 洋幸 TSUDA Hiroyuki
    • 名古屋市立大学大学院医学研究科・分子毒性学分野(分子医学講座生体防御・総合医学専攻) Department of Molecular Toxicology, Graduate School of Medical Sciences, Nagoya City University
    • 徳永 裕司 TOKUNAGA Hiroshi
    • 国立医薬品食品衛生研究所環境衛生化学部:(現)医薬品医療機器総合機構品質管理部基準課 Division of Environmental Chemistry, National Institute of Health Sciences
    • 広瀬 明彦 HIROSE Akihiko
    • 国立医薬品食品衛生研究所安全性生物試験研究センター総合評価研究室 Division of Risk Assessment, Biological Safety Research Center, National Institute of Health Sciences
    • 菅野 純 KANNO Jun
    • 国立医薬品食品衛生研究所安全性生物試験研究センター毒性部 Division of Cellular and Molecular Toxicology, Biological Safety Research Center, National Institute of Health Sciences

Abstract

It is considered that the materials with new properties may lead to novel biological effects or unknown adverse health effects. To gather proper hazard information, it is important to develop both experimental protocols and detection/measurement methods for nanomaterials in the body, in parallel. Since 2005, we are running research projects to develop methods to monitor health risk effects for the assessment of manufactured nanomaterials funded by the Ministry of Health, Labour and Welfare. For the experimental protocols, these projects focus on the development of 1) in vitro experimental systems, 2) in vivo experimental systems (mainly focusing on long-term health implication, especially carcinogenesis), and 3) proper inhalation system. Firstly, fullerene (C60), titanium dioxide and multi-walled carbon nanotube were chosen to be tested because of their high production volume. Safety issues for new materials such as nanoparticles is a new paradigm. The key is that the full scale exposure to the public has not been started yet. Therefore, there is a good chance that information from hazard identification studies can be directly fed back to the product development plan. Manufacturers can produce safer products without risking themselves waiting for the toxicology studies to be finished after their products are widely marketed.

Journal

Journal of the Pharmaceutical Society of Japan   [List of Volumes]

Journal of the Pharmaceutical Society of Japan 128(12), 1727-1732, 2008-12-01  [Table of Contents]

The Pharmaceutical Society of Japan

References:  17

You must have a user ID to see the references.If you already have a user ID, please click "Login" to access the info.New users can click "Sign Up" to register for an user ID.

Preview

Preview

Codes

  • NII Article ID (NAID) :
    110007005954
  • NII NACSIS-CAT ID (NCID) :
    AN00284903
  • Text Lang :
    JPN
  • Article Type :
    REV
  • ISSN :
    00316903
  • NDL Article ID :
    9732634
  • NDL Source Classification :
    ZS51(科学技術--薬学)
  • NDL Call No. :
    Z19-411
  • Databases :
    CJP  NDL  NII-ELS  J-STAGE